Omnicell (OMCL) Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last twelve months. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OMCL shares.
View OMCL analyst ratings or view top-rated stocks.

8 brokerages have issued twelve-month price objectives for Omnicell's shares. Their OMCL share price forecasts range from $54.00 to $120.00. On average, they expect the company's stock price to reach $72.22 in the next year. This suggests that the stock has a possible downside of 1.0%.
View analysts price targets for OMCL or view top-rated stocks among Wall Street analysts.

Omnicell's stock was trading at $50.42 at the beginning of the year. Since then, OMCL shares have increased by 44.6% and is now trading at $72.92.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our OMCL earnings forecast.

Omnicell, Inc. (NASDAQ:OMCL) posted its earnings results on Tuesday, November, 2nd. The company reported $1.08 EPS for the quarter, beating analysts' consensus estimates of $0.63 by $0.45. The firm earned $296.40 million during the quarter, compared to analyst estimates of $283.82 million. Omnicell had a positive trailing twelve-month return on equity of 5.38% and a negative net margin of 1.39%. During the same quarter in the prior year, the firm earned $0.40 EPS.

ETFs with the largest weight of Omnicell (NASDAQ:OMCL) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Robo Global Robotics and Automation Index ETF (ROBO), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ), SPDR S&P Health Care Equipment ETF (XHE), Invesco Nasdaq Future Gen 200 ETF (QQQS), First Trust Multi-Manager Small Cap Opportunities ETF (MMSC) and Vanguard Russell 2000 Growth ETF (VTWG).

Omnicell issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of $1.55-$1.80 for the period, compared to the consensus EPS estimate of $1.63. The company issued revenue guidance of $1.15 billion-$1.19 billion, compared to the consensus revenue estimate of $1.17 billion.

150 employees have rated Omnicell Chief Executive Officer Randall A. Lipps on Glassdoor.com. Randall A. Lipps has an approval rating of 68% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Adobe (ADBE), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Alibaba Group (BABA) and Intel (INTC).

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Omnicell's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (8.46%), Clearbridge Investments LLC (2.65%), Conestoga Capital Advisors LLC (2.51%), ArrowMark Colorado Holdings LLC (2.23%), Champlain Investment Partners LLC (2.18%) and Geode Capital Management LLC (1.95%). Insiders that own company stock include Christine Marie Mellon, Dan S Johnston, James T Judson, Joanne B Bauer, Joseph Brian Spears, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann.
View institutional ownership trends.

Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OMCL stock can currently be purchased for approximately $72.92.

Omnicell (NASDAQ:OMCL) has a market capitalization of $3.29 billion and generates $1.30 billion in revenue each year. The company earns $5.65 million in net income (profit) each year or ($0.40) on an earnings per share basis.

The company employs 4,230 workers across the globe.

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The official website for the company is www.omnicell.com. The company can be reached via phone at (877) 415-9990, via email at ir@omnicell.com, or via fax at 847-596-3402.